U.S. Stock News

In early August 2026, LTC Properties, Inc. reported sharply higher second-quarter and year-to-date revenue and net income, completed a US$311.4 million at-the-market equity raise from a US$500 million program, and increased its full-year 2026 diluted earnings guidance to US$8.08–US$8.10 per common share. Management highlighted rapid expansion of the SHOP senior housing platform from US$175 million to over US$1.30 billions of gross investments in about fifteen months, emphasizing acquisitions...

GLOBALFOUNDRIES (GFS) stock is back in focus after the company selected Redpanda as a key partner for a unified real-time data platform that links manufacturing, engineering and business systems across its global operations. See our latest analysis for GLOBALFOUNDRIES. The Redpanda partnership and recent earnings guidance arrive after a mixed stretch for GLOBALFOUNDRIES, with the share price down 29.51% over three months but still showing a 35.34% year to date share price return and a 50.43%...

Enliven Therapeutics earnings update and what it means for the stock Enliven Therapeutics (ELVN) recently reported second quarter and six month results to 30 June 2026. The company posted a quarterly net loss of US$32.49 million and a six month net loss of US$56.11 million. Basic loss per share from continuing operations held at US$0.49 for the quarter compared with the same period last year. Over the six month period, basic loss per share from continuing operations was US$0.87 compared with...

Bicara Therapeutics (BCAX) is reshaping its executive team around the potential commercialization of its lead cancer therapy, ficerafusp alfa, with a planned CEO transition and new CFO, COO, and legal leadership. See our latest analysis for Bicara Therapeutics. Bicara Therapeutics’ recent leadership reshuffle and shelf registration have arrived alongside a 1-day share price return of 2.72% to $24.94, after a 7-day share price return that declined 10.06% and a year-to-date share price return...

Strive stock has had a very weak year, with the share price down about 84.2% over the past 12 months, while the latest valuation checks send a mixed message that includes an undervalued read on market multiples but a low overall value score. Over the last year, Strive has declined 84.2%, which puts recent short term gains into the context of a much larger drawdown. For Strive, any improvement in converting revenue into dependable cash flow can support the current share price, while pressure...

Amphenol (APH) is back in focus after the company approved its third quarter 2026 dividend of $0.25 per share, or $0.125 post split. This has reinforced attention on its recent share price gains. See our latest analysis for Amphenol. At a share price of $159.57, Amphenol has slipped 6.61% on a 1-day basis and 4.58% over the past week. Its 90-day share price return of 29.68% and 1-year total shareholder return of 46.08% point to momentum that investors are now weighing against richer...

H World Group stock slipped about 1.5% today, even though the earnings story pointed in the opposite emotional direction. You had a hotel operator already trading on a trailing P/E below broader hospitality peers. Then it delivered Q2 revenue of RMB 7,121m with adjusted net income of roughly RMB 1,700m and a wider adjusted EBITDA margin of 38.3%. The market treated this like a mild headache. The numbers looked more like a company quietly tightening its profit engine. Is H World Group trading...

Flexsteel Industries just saw its stock jump 8.9% to US$77.16, and the move was not driven by sentiment alone. Furniture investors went in expecting cautious guidance and modest profit, yet the headline from this quarter is margin power. Q4 revenue landed at about US$115.4m while basic earnings per share reached roughly US$2.82, capping a year in which net profit margin improved meaningfully and record trailing earnings met a still modest 12.5x P/E. The contrast between a cautious earnings...

UnitedHealth Group (NYSE: UNH) faces a new shareholder lawsuit alleging it ignored governance and cybersecurity risks tied to major Medicare fraud and a historic healthcare data breach. The complaint claims internal audits were shut down and an acquisition was rushed, which investors say contributed to what they describe as the largest healthcare data breach in U.S. history. The filing argues that UnitedHealth Group failed to maintain adequate internal controls, exposing the company to...

Bandwidth (BAND) has drawn attention after a sharp share price move over the past month, with the stock down about 26%. That shift is prompting fresh interest in how its fundamentals line up. See our latest analysis for Bandwidth. The recent 26% 30 day share price decline contrasts sharply with Bandwidth's very large year to date share price return of about 272%, which mirrors a similarly very large 1 year total shareholder return near 270%. This suggests that momentum has started to cool...

Chemed Corporation recently declared a quarterly cash dividend of US$0.70 per share, paid on September 3, 2026, to shareholders of record as of August 17, 2026, representing a 10‑cent increase over the June payout and marking its 221st consecutive quarterly dividend in 55 years as a public company. This long-running pattern of uninterrupted quarterly dividends, alongside a recent 17% increase, underlines how consistently Chemed has prioritized direct cash returns to shareholders. With this...

In recent weeks, Nike has faced pressure from weak quarterly results, cautious consumer demand, analyst downgrades, and leadership changes, including the appointment of a new chief financial officer and the pending resignation of its chief accounting officer. At the same time, the company is leaning into community-focused initiatives such as The Crenshaw Rec by Foot Locker, developed with Nike, Jordan Brand, and Converse to deepen cultural relevance and brand engagement. These developments...

Capital Clean Energy Carriers (CCEC) is back on investor radars after updating progress on its US$20 million share repurchase program and taking delivery of its 15th latest generation LNG carrier, Alcaios I. See our latest analysis for Capital Clean Energy Carriers. Recent updates from Capital Clean Energy Carriers on its US$20 million buyback and growing LNG fleet come against a backdrop of steady price momentum, with the share price delivering a 10.49% year to date return and a 5 year total...

Why Sana Biotechnology’s Latest Earnings Matter For Investors Sana Biotechnology (SANA) recently reported second quarter and half year 2026 results, showing narrower net losses and lower basic loss per share compared with the same periods a year earlier. The company recorded a second quarter net loss of US$63.64 million and basic loss per share from continuing operations of US$0.22. For the six month period, net loss was US$110.85 million with basic loss per share of US$0.39. See our latest...

Recently, analysts highlighted that Agnico Eagle Mines is expected to face higher all-in sustaining costs as production expenses, royalties and sustaining capital rise, pressuring profitability relative to earlier expectations. At the same time, a contrast has emerged between bullish brokerage recommendations and a more cautious Zacks Rank based on earnings estimate revisions, underscoring differing views on Agnico Eagle’s near-term outlook. Next, we’ll examine how these expectations of...

BitFuFu stock closed flat at US$1.29 after Q2, which suggests the market has not made up its mind. The headline is a tug of war between a reported net loss of US$20.6 million and an operating picture that looks far less bleak once fair value swings on Bitcoin are stripped out. For a Bitcoin miner, power cost and hashrate efficiency matter more than headline revenue. BitFuFu leaned into that by keeping fleet efficiency competitive and driving electricity at its Oklahoma site to about US$0.03...

Zenas BioPharma (ZBIO) is back in focus after second quarter 2026 results showed revenue of US$1 million alongside a net loss of US$111.46 million, paired with several senior leadership changes. See our latest analysis for Zenas BioPharma. At a share price of US$31.91, Zenas BioPharma has seen a 90 day share price return of 63.14%, while the year to date share price return is down 7.51% and the 1 year total shareholder return is 101.32%. This suggests recent momentum has picked up even as the...

After a strong multi year run, NetApp now trades at levels where its share price and the latest intrinsic value estimate are broadly in line, even as its broader valuation checks still lean expensive. NetApp has returned 184.0% over the past 5 years, which puts recent gains into a longer term context that investors need to factor into any valuation view. The acquisition of JetStream Software may support expectations for future data protection and cloud related cash flows. However,...

Camtek guidance and Q2 results put recent stock move in focus Camtek (NasdaqGM:CAMT) has drawn fresh attention after record second quarter revenue tied to Advanced Packaging for AI uses, rapid order intake above US$600 million year to date, and upbeat third quarter guidance. See our latest analysis for Camtek. Camtek's recent Q2 update and strong third quarter revenue guidance appear to have fed into building momentum, with a 1‑month share price return of 17.55% and a year to date share price...

Duolingo (DUOL) is back in focus after acquiring London based animation studio Animade. The move is aimed at strengthening user engagement and product experience following its recent second quarter 2026 earnings update. See our latest analysis for Duolingo. The recent Animade acquisition and Duolingo’s August earnings and guidance updates have come alongside a 90 day share price return of 30.72%, while the year to date share price is down 20.87% and the 1 year total shareholder return is down...

Why Aflac Stock Is In Focus After Q2 Earnings And Capital Returns Update Aflac (AFL) is drawing fresh attention after reporting second quarter 2026 results, affirming a $0.61 third quarter dividend, and updating investors on progress under its long running share repurchase program. See our latest analysis for Aflac. Aflac's share price has a 90 day share price return of 3.85% and a year to date share price return of 10.42%. The 5 year total shareholder return of 139.16% points to momentum...

International Business Machines Corporation recently announced a multi-year US$240 million collaboration with Together AI to deploy a large Nvidia HGX B300 inference cluster on IBM Cloud by early 2027, alongside an expanded partnership with OpenAI to embed frontier models such as GPT-5.6, Codex, and ChatGPT Work into IBM Consulting Advantage and cybersecurity offerings. By pairing OpenAI’s frontier AI models with IBM’s consulting, cloud, and autonomous security platforms, IBM is positioning...

Northrop Grumman (NYSE:NOC) and Kratos Defense & Security Solutions received a U.S. Marine Corps contract to develop the Missionized Valkyrie Air Vehicle for the MUX TACAIR program. The Missionized Valkyrie will use Northrop Grumman’s mission kit and Open Architecture Autonomy Software for unmanned tactical aviation. The award expands Northrop Grumman’s role in unmanned systems for the Marine Air-Ground Task Force. Consider using this news as a starting point to review other defense and...

CDW (CDW) has drawn fresh investor attention after reporting second quarter 2026 results, including sales of US$6,572.2m and net income of US$274.4m, along with a declared quarterly dividend of US$0.630 per share. See our latest analysis for CDW. At a share price of US$134.97, CDW has recently seen a 90 day share price return of 27.08%, while the 1 year total shareholder return declined 17.90%. This suggests that recent momentum contrasts with weaker longer term outcomes. If CDW’s recent move...